STAGE IV NON-SMALL CELL LUNG CANCER
Clinical trials for STAGE IV NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IV NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for STAGE IV NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test could personalize lung cancer therapy
Disease control Recruiting nowThis study is for people with advanced non-small cell lung cancer whose tumors have high PD-L1 levels. Researchers want to see if a blood test that measures tumor DNA (ctDNA) can help decide whether to add chemotherapy to the immunotherapy drug cemiplimab. About 63 participants w…
Matched conditions: STAGE IV NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Fundación GECP • Aim: Disease control
Last updated May 17, 2026 02:04 UTC
-
Immune cells supercharged to fight hard-to-treat lung cancer
Disease control Recruiting nowThis early-phase trial tests a special immune cell treatment (CD40L TIL) combined with the drug nivolumab for people with advanced non-small cell lung cancer that has specific gene changes (EGFR, ALK, ROS1, or HER2). The study aims to see if this approach is safe and can shrink t…
Matched conditions: STAGE IV NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
Ohio study aims to beat lung cancer with tailored treatments
Disease control Recruiting nowThis study is testing whether a personalized care plan, which includes advanced genomic testing and immunotherapy, can help people with stage IV non-small cell lung cancer live longer and feel better. About 3,500 current or former smokers with this cancer will be followed to see …
Matched conditions: STAGE IV NON-SMALL CELL LUNG CANCER
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
New program aims to ease emotional burden of advanced lung cancer
Symptom relief Recruiting nowThis study is testing a new supportive care program called POISE for people with advanced non-small cell lung cancer. The program includes four visits with a specially trained palliative care clinician to help patients cope with uncertainty and manage their cancer journey. Resear…
Matched conditions: STAGE IV NON-SMALL CELL LUNG CANCER
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 17, 2026 02:19 UTC